Integra LifeSciences Holdings (IART)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 5.73 | 5.72 | 6.62 | 5.76 | 5.31 | |
| DSO | days | 63.68 | 63.83 | 55.16 | 63.39 | 68.75 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.73
= 63.68
The Days Sales Outstanding (DSO) for Integra LifeSciences Holdings has shown varying trends over the past five years. In 2023, the DSO was at 63.68 days, slightly lower than the preceding year of 63.83 days. This indicates that the company took approximately 63.68 days on average to collect its accounts receivable in 2023.
Comparing to 2021, where the DSO was at 55.16 days, the 2023 DSO increased, suggesting a potential deterioration in the company's collection efficiency. However, it is worth noting that the DSO in 2023 was lower than in 2019, which was 68.75 days, showing some improvement in receivables management over the span of five years.
Overall, the trend in DSO for Integra LifeSciences Holdings indicates some fluctuations in the efficiency of the company's accounts receivable collection process. Further analysis of the underlying factors affecting DSO over the years could provide insights into the company's credit policies and customer payment behavior.
Peer comparison
Dec 31, 2023